
Nolan Beilstein
Associate Editor, Industrial Media, LLC at Industrial Equipment News (IEN)
Articles
-
1 week ago |
thomasnet.com | Nolan Beilstein |Audrey Altmann
The U.S. Air Force unveiled a rendering of its AGM-181A Long-Range Standoff missile developed by Raytheon Technologies. New Atlas reported that the military branch began flight testing and expects the weapon to replace the Cold War-era AGM-86B Air-Launched Cruise missile. The report stated that the new 287-pound air-breathing cruise missile can autonomously navigate to a target and launch from either the B-52 Stratofortress or B-21 Raider bombers.
-
1 week ago |
yahoo.com | Nolan Beilstein
The Oregonian reported that chipmaker Intel plans to lay off up to 20% of its factory workforce, citing an internal email the publication says was verified by four employees. According to the report, Intel informed its employees that the cuts would begin taking effect in July and would impact factories worldwide.
-
1 week ago |
manufacturing.net | Nolan Beilstein
TranscriptThe Oregonian reported that chipmaker Intel plans to lay off up to 20% of its factory workforce, citing an internal email the publication says was verified by four employees. According to the report, Intel informed its employees that the cuts would begin taking effect in July and would impact factories worldwide.
-
1 week ago |
thomasnet.com | Nolan Beilstein |Audrey Altmann
Kratos Defense & Security Solutions plans to open a manufacturing site in Bristow, Oklahoma, to build its GE Aerospace-Kratos (GEK) line of turbojet engines. The company made the announcement in France prior to this year’s Paris Air Show. The company anticipates moving in by mid-2026 and scaling operations by the end of that year. The facility will initially produce the GEK800.
-
1 week ago |
thomasnet.com | Nolan Beilstein |Audrey Altmann
Belgian biopharmaceutical company UCB announced plans to establish a new biologics manufacturing facility in the U.S. The company expects the investment to deliver an economic impact of about $5 billion and support its expanding U.S. patient base with severe immune system or central nervous system diseases. UCB anticipates the factory will create nearly 300 biologics manufacturing jobs and over 500 construction jobs. The company has not chosen a location for the factory.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →